CELU

Haines John R

Known title: See RemarksCIK: 0001867686

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 1, 2026

Celularity Q1 2027 EPS Up, Announces Partner & Board Member. Celularity posted a first‑quarter 2027 earnings per share of $0.02, up from a loss of $0.84 a year earlier, while sales fell to $3.85 million from $11.43 million. The company will open the Fontaine Vitale facility with its strategic partner and added Naveen Jain to its board. It also closed a $10 million private placement of senior secured convertible notes and warrants, part of a $28 million recapitalization plan.

this person other insiders at CELU

Transaction History

CELU▲ Buy$0
CELU▼ Sell$746
CELU▲ Buy$0
CELU▼ Sell$946
CELU▼ Sell$15K
CELU▲ Buy$0
CELU▼ Sell$2K
CELU▼ Sell$31K
CELU▼ Sell$4K
CELU▲ Buy—
CELU▲ Buy—

We use analytics to understand how market-wall is used. No personal data is sold.